Henry Schein, Inc. (NASDAQ:HSIC) Short Interest Up 14.1% in May

Henry Schein, Inc. (NASDAQ:HSIC) was the target of a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 6,060,000 shares, an increase of 14.1% from the May 15th total of 5,310,000 shares. Approximately 4.8% of the shares of the company are sold short. Based on an average daily volume of 1,010,000 shares, the short-interest ratio is presently 6.0 days.

Insider Activity

In related news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the sale, the chief executive officer now owns 73,108 shares in the company, valued at $5,430,462.24. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 1.14% of the company’s stock.

Institutional Trading of Henry Schein

Hedge funds and other institutional investors have recently modified their holdings of the company. Swedbank AB acquired a new stake in shares of Henry Schein during the first quarter worth $215,998,000. Wahed Invest LLC raised its position in shares of Henry Schein by 14.3% during the first quarter. Wahed Invest LLC now owns 2,540 shares of the company’s stock worth $192,000 after purchasing an additional 318 shares during the period. Tidal Investments LLC raised its position in shares of Henry Schein by 21.4% during the first quarter. Tidal Investments LLC now owns 5,632 shares of the company’s stock worth $425,000 after purchasing an additional 994 shares during the period. California State Teachers Retirement System raised its position in shares of Henry Schein by 1.7% during the first quarter. California State Teachers Retirement System now owns 212,108 shares of the company’s stock worth $16,018,000 after purchasing an additional 3,534 shares during the period. Finally, Magnetar Financial LLC raised its position in shares of Henry Schein by 229.9% during the first quarter. Magnetar Financial LLC now owns 386,458 shares of the company’s stock worth $29,185,000 after purchasing an additional 269,330 shares during the period. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Performance

NASDAQ:HSIC traded up $1.44 during midday trading on Tuesday, reaching $67.62. 207,984 shares of the company traded hands, compared to its average volume of 1,062,047. Henry Schein has a twelve month low of $60.01 and a twelve month high of $82.63. The firm has a market capitalization of $8.66 billion, a price-to-earnings ratio of 22.36, a price-to-earnings-growth ratio of 1.62 and a beta of 0.90. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02. The company has a fifty day moving average price of $70.79 and a 200 day moving average price of $73.20.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.01 by $0.09. The firm had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.21 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The firm’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.21 EPS. On average, analysts expect that Henry Schein will post 5.17 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts have commented on HSIC shares. Barrington Research lifted their price target on Henry Schein from $90.00 to $92.00 and gave the company an “outperform” rating in a report on Wednesday, May 8th. SVB Leerink assumed coverage on shares of Henry Schein in a research note on Monday, February 26th. They set a “market perform” rating and a $78.00 price objective for the company. UBS Group cut their target price on Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 8th. Leerink Partnrs reissued a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th. Finally, Piper Sandler raised their price objective on Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a report on Monday, February 26th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $81.73.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.